CYTOKINETICS INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $88.0M | $18.5M | $7.5M | $94.6M | $70.4M |
| Operating income | -$612.3M | -$536.2M | -$496.2M | -$324.2M | -$186.3M |
| Operating expenses | $700.3M | $554.7M | $503.7M | $418.8M | $256.7M |
| Cash from operations | -$510.0M | -$395.9M | -$414.3M | -$299.5M | -$142.5M |
| Capital expenditure | $24.8M | $3.9M | $1.4M | $11.3M | $48.9M |
| Free cash flow | -$534.8M | -$399.8M | -$415.7M | -$310.9M | -$191.4M |
| Total assets | $1.4B | $1.4B | $824.3M | $1.0B | $841.3M |
| Total liabilities | $2.1B | $1.5B | $1.2B | $1.1B | $597.5M |
| Total debt | $999.0M | — | — | — | — |
Shares outstanding 124.4M · Free float 94.1%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.